Distinctive RNA Expression Profiles in Blood Associated With Alzheimer Disease After Accounting for White Matter Hyperintensities

Enhanced Proteolytic Clearance of Plasma A  by Peripherally Administered Neprilysin Does Not Result in Reduced Levels of Brain A  in Mice

(2013) J. R. Walker et al.   JOURNAL OF NEUROSCIENCE

The impairment of insulin signaling in Alzheimer's disease

(2012) Emanuel Candeias et al.   IUBMB LIFE

A 1-42-RAGE Interaction Disrupts Tight Junctions of the Blood-Brain Barrier Via Ca2+-Calcineurin Signaling

(2012) S.-Y. Kook et al.   JOURNAL OF NEUROSCIENCE

Concerted Perturbation Observed in a Hub Network in Alzheimer’s Disease

(2012) Dapeng Liang et al.   PLoS One

The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression

(2011) Filippo Caraci et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Beta-amyloid increases the expression level of ATBF1 responsible for death in cultured cortical neurons

(2011) Cha-Gyun Jung et al.   Molecular Neurodegeneration

Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: A study in the MRC-CFAS population neuropathology cohort

(2011) Andrew P. Viggars et al.   NEUROSCIENCE LETTERS

Peripheral Delivery of a CNS Targeted, Metalo-Protease Reduces Aβ Toxicity in a Mouse Model of Alzheimer's Disease

(2011) Brian Spencer et al.   PLoS One

Toward an Alzheimer's disease diagnosis via high-resolution blood gene expression

(2010) Pascale Fehlbaum-Beurdeley et al.   Alzheimers & Dementia

Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis

(2010) Norman J. Haughey et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Predictive Value of Platelet Activation for the Rate of Cognitive Decline in Alzheimer's Disease Patients

(2010) Konstantinos Stellos et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Distinctive RNA Expression Profiles in Blood Associated With White Matter Hyperintensities in Brain

(2010) Huichun Xu et al.   STROKE

Neprilysin Overexpression Inhibits Plaque Formation But Fails to Reduce Pathogenic A  Oligomers and Associated Cognitive Deficits in Human Amyloid Precursor Protein Transgenic Mice

(2009) W. J. Meilandt et al.   JOURNAL OF NEUROSCIENCE

Methodology for Discovery of Alzheimer's Disease Blood-Based Biomarkers

(2009) Olivier C. Maes et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Association of Distinct Variants in SORL1 With Cerebrovascular and Neurodegenerative Changes Related to Alzheimer Disease

(2008) Karen T. Cuenco   ARCHIVES OF NEUROLOGY

Transglutaminases and Transglutaminase-Catalyzed Cross-Links Colocalize with the Pathological Lesions in Alzheimer's Disease Brain

(2008) Micha M.M. Wilhelmus et al.   BRAIN PATHOLOGY

Peripherally expressed neprilysin reduces brain amyloid burden: A novel approach for treating Alzheimer's disease

(2008) Hanjun Guan et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Differential cerebral deposition of IDE and NEP in sporadic and familial Alzheimer's disease

(2008) Verónica Berta Dorfman et al.   NEUROBIOLOGY OF AGING

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

(2008) Aileen M. Moloney et al.   NEUROBIOLOGY OF AGING

Human membrane metallo-endopeptidase-like protein degrades both beta-amyloid 42 and beta-amyloid 40

(2008) J.Y. Huang et al.   NEUROSCIENCE

Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP+PS1 transgenic mouse brains

(2007) A. Amritraj et al.   NEUROBIOLOGY OF AGING

TGF-β1 is increased in a transgenic mouse model of familial Alzheimer's disease and causes neuronal apoptosis

(2007) Pradeep Salins et al.   NEUROSCIENCE LETTERS